CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy remains the standard treatment for ALCL and good response is seen in ALK-positive ALCL except for those with multiple IPI adverse factors [11]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.